Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07498530
CompletedNCT07498530ClinicalTrials.gov record

Virtual Assistant for Exercise Adherence in Older ADULTS

Older Adult · Exercise · Adherence · Prevention · New Technologies

THE QUICK READ

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type
Interventional
Phase
Not applicable
Age range
59 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
78 Actual

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

This study will evaluate the effectiveness of a virtual assistant-guided exercise program to improve adherence in older adults. In a nonrandomized controlled clinical trial, the experimental group will complete a 12-week, home-based program (60-minute sessions, 3 times per week) supported by a virtual assistant (BOT). The control group will comprise community-dwelling older adults already engaged in the municipal program Enguera se saludable, which delivers an in-person exercise program of comparable frequency and duration. The primary outcome is exercise adherence, defined as the proportion of prescribed sessions completed. Secondary outcomes include muscle strength, balance, functional capacity, health-related quality of life, and the user experience and usability of the virtual assistant.

Read the full description

The objective of this study is to determine whether a virtual assistant-controlled, home-based exercise program can improve adherence to therapeutic exercise among older adults, compared with a conventional municipal program of similar dosage. Although exercise is effective for preserving function and quality of life during aging, adherence remains suboptimal. Virtual assistants may offer a scalable and acceptable solution to support sustained participation.

The study will employ a nonrandomized controlled clinical trial (quasi-experimental design) involving community-dwelling adults aged ≥60 years. Participants will be allocated to groups based on program pathway:

Experimental group (Virtual Assistant/BOT): a structured home-based exercise program (60 minutes per session, 3 sessions per week for 12 weeks), guided and monitored by a virtual assistant (BOT), including automated session delivery, reminders, and adherence tracking.

Control group (Municipal program): older adults already participating in Enguera se saludable, an onsite, instructor-led municipal program with equivalent frequency and duration (60 minutes, 3 times per week for 12 weeks). Attendance records from the municipal program will quantify adherence.

The primary outcome is exercise adherence, defined as the proportion of prescribed sessions completed during the 12-week period, with predefined adherence thresholds (e.g., ≥75% of sessions completed). Secondary outcomes include changes in muscle strength, balance, functional performance, and health-related quality of life. Additional measures will include user perceptions, usability, and satisfaction with the virtual assistant to evaluate acceptability and feasibility.

Given the nonrandomized design and the pre-existing enrollment of the control group, the study will incorporate the following methodological safeguards:

Baseline demographic and clinical characteristics (e.g., age, sex, comorbidities, prior activity level) will be comprehensively documented.

Baseline imbalances will be controlled through statistical adjustment (e.g., covariate adjustment, propensity score procedures, and sensitivity analyses) to reduce selection bias and confounding.

Exercise dosage (frequency, duration, and intervention length) will be matched across groups, or, when small discrepancies arise, dosage will be included as a covariate in the analyses.

This study is expected to contribute evidence regarding whether a virtual assistant-based exercise program represents a viable, effective, and acceptable alternative to conventional program delivery models for promoting active and healthy aging in community-dwelling older adults.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Adults aged 60 years or older.
  • Community-dwelling individuals capable of participating in an exercise program.
  • Ability to complete 60-minute exercise sessions, three times per week during the 12-week intervention.
  • Experimental group (BOT Group): Participants willing to use a smartphone/tablet and interact with the virtual assistant.
  • Control group (Municipal Exercise Group): Individuals already enrolled in the municipal program Enguera se saludable.
  • Ability to understand the study procedures and provide written informed consent

Exclusion Criteria:

  • Medical contraindications to physical exercise, as determined by clinical judgment (e.g., uncontrolled cardiovascular, respiratory, or metabolic conditions).
  • Severe cognitive impairment or neurological conditions that limit the ability to follow instructions or safely perform the exercise program.
  • Severe mobility limitations preventing participation in structured exercise (e.g., inability to walk independently with or without aid).
  • Acute musculoskeletal injuries or recent surgeries that contraindicate exercise participation.
  • Individuals currently participating in another structured exercise program that would interfere with the study interventions (other than Enguera se saludable for the control group).
  • Inability or unwillingness to comply with the requirements of the study (frequency, duration, assessments).
  • For the BOT group: lack of access to a device compatible with the virtual assistant or inability/unwillingness to use it.
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not randomized
Masking
Double masked
Bot Group

Participants in this group will complete a 12-week home-based exercise program delivered and monitored by a virtual assistant (BOT). The program consists of 60-minute sessions, three times per week, including guided instructions, automated reminders, and adherence tracking. The BOT provides real-time session support and records participation throughout the intervention.

Procedure: Exercise program

Enguera program Group

Participants in this group are individuals already enrolled in the municipal program "Enguera se saludable", which offers a face-to-face, instructor-led exercise program of the same duration and frequency (60 minutes, three times per week for 12 weeks). Attendance is recorded routinely by program instructors and will be used to assess adherence.

Procedure: Exercise program

Exercise program PROCEDURE

BOT Group: Home-based exercise program delivered through a virtual assistant for 12 weeks (60 minutes, three times per week), including guided instructions and adherence monitoring.

Enguera Exercise Group: Face-to-face, instructor-led exercise sessions from the Enguera se saludable program, with the same frequency and duration (60 minutes, three times per week for 12 weeks).

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Exercise Adherence (% of prescribed sessions completed)

Time frame: End of the 12-week intervention.

Exercise adherence will be defined as the percentage of prescribed exercise sessions completed during the 12-week intervention. A single adherence value will be calculated for each participant as:

\\text{Adherence (%) = (Sessions completed / Sessions prescribed) × 100}

Measurement method:

Virtual Assistant/BOT Group: Adherence will be recorded automatically by the virtual assistant (BOT), which logs session completion in real time.

Municipal Exercise Group: Adherence will be calculated from attendance records routinely collected in the Enguera se saludable municipal program, using the same formula (completed / prescribed × 100).

Although adherence is obtained from different data sources, the measurement itself is identical in both groups, expressed as a percentage (%).

Secondary measures

Physical performance assessed by the Short Physical Performance Battery (SPPB)

Time frame: Baseline and 12 weeks.

Lower-limb functional performance will be assessed using the Short Physical Performance Battery (SPPB), a validated instrument for older adults. The SPPB includes three components: balance tests, gait speed, and the 5-times sit-to-stand test. Each component is scored from 0 to 4, yielding a total score from 0 to 12, with higher scores indicating better physical performance.

Unit of measurement:

SPPB total score (0-12 points).

Accelerometry-Based Physical Activity (Moderate-to-Vigorous Activity Levels)

Time frame: Baseline and 12 weeks

Moderate-to-vigorous physical activity (MVPA) will be quantified using a wrist- or hip-worn triaxial accelerometer. MVPA will be calculated according to established cut-points for older adults, expressed as minutes per day accumulated at moderate or vigorous intensity. Devices will be worn during the monitoring period, and raw acceleration data will be processed using standardized algorithms to derive daily MVPA time. A single MVPA value will be generated for each assessment period.

Unit of measurement:

Minutes/day of MVPA (moderate-to-vigorous physical activity).

Risk of falls measured by the FallSkip® system (Fall Risk Index, 0-100)

Time frame: Baseline and 12 weeks

Risk of falls will be assessed using the FallSkip® system, an instrumented device that evaluates fall risk in older adults through a standardized functional protocol. The device records parameters such as reaction time, postural stability, gait acceleration/deceleration patterns, and sit-to-stand performance. These variables are integrated automatically by the device software to generate a Fall Risk Index on a 0-100 scale, with higher values indicating greater risk of falls. A single Fall Risk Index score will be obtained for each participant at every assessment time point.

Unit of measurement:

FallSkip® Fall Risk Index (0-100 points).

User experience and usability of the virtual assistant measured with a Visual Analog Scale (VAS)

Time frame: 12 weeks.

User experience and usability of the virtual assistant (BOT) will be evaluated using a Visual Analog Scale (VAS), an anchored numerical scale ranging from 0 to 10, in which 0 represents the worst possible user experience/usability and 10 represents the best possible user experience/usability. Participants will rate their overall experience and perceived usability of the virtual assistant on this single-item scale. A single VAS score will be obtained for each assessment period.

Unit of measurement:

Score on the Visual Analog Scale (0-10), where higher scores indicate better user experience/usability.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Carmen García GomarizValencia, SpainStatus unknown

Study team and timeline

Lead sponsor
University of Valencia
Study start
Apr 4, 2026 Actual
Primary completion
Nov 8, 2026 Actual
Study completion
Nov 9, 2026 Actual
First posted
Mar 27, 2026 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.

Official study title

Application of a Virtual Assistant to Enhance Exercise Adherence in Older Adults

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026